HonCode

Go Back   HER2 Support Group Forums > General Cancer News
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply
 
Thread Tools Display Modes
Old 01-10-2013, 10:20 PM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,905
TapImmune announces results from HER2/neu interim study on breast cancer

TapImmune Inc. has announced that an interim safety analysis on the first five breast cancer patients treated with HER2/neu Class II antigens at Mayo Clinic, Rochester, MN., did not show any serious adverse events.

More...
News is offline   Reply With Quote
Old 01-11-2013, 07:12 PM   #2
Cure4Cat
Senior Member
 
Join Date: Mar 2011
Posts: 48
Re: TapImmune announces results from HER2/neu interim study on breast cancer

I was just about to post the link to this article but I see it is already here. I have been following this study. This seems like great progress, but oh, how I wish these trials could go faster! One step closer, I guess!
__________________
Dx Her2+, ER+, PR-, stage 2b/3 July 2010
Chemo Sept-Dec 2010
(Pertuzumab during last 3 rounds of chemo)
Surgery Jan 2011
25 Rads March 2011
Herceptin started during chemo and continued every 3 weeks for 1 year
Started Tamoxifen for 5 years

Looking for a vaccine trial
Cure4Cat is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 06:38 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter